<VariationArchive VariationID="56732" VariationName="NM_025114.4(CEP290):c.1860_1861del (p.Asp622fs)" VariationType="Deletion" Accession="VCV000056732" Version="5" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-03-05" DateCreated="2013-07-24" MostRecentSubmission="2024-02-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="71371" VariationID="56732">
      <GeneList>
        <Gene Symbol="CEP290" FullName="centrosomal protein 290" GeneID="80184" HGNC_ID="HGNC:29021" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>12q21.32</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="12" Accession="NC_000012.12" start="88049016" stop="88142088" display_start="88049016" display_stop="88142088" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="12" Accession="NC_000012.11" start="88442789" stop="88535992" display_start="88442789" display_stop="88535992" Strand="-" />
          </Location>
          <OMIM>610142</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_025114.4(CEP290):c.1860_1861del (p.Asp622fs)</Name>
      <CanonicalSPDI>NC_000012.12:88115145:TTT:T</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>12q21.32</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="12" Accession="NC_000012.12" start="88115146" stop="88115147" display_start="88115146" display_stop="88115147" variantLength="2" positionVCF="88115145" referenceAlleleVCF="CTT" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="12" Accession="NC_000012.11" start="88508923" stop="88508924" display_start="88508923" display_stop="88508924" variantLength="2" positionVCF="88508922" referenceAlleleVCF="CTT" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>D622fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_694" sequenceAccession="LRG_694">
            <Expression>LRG_694:g.32070_32071del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_694t1" sequenceAccession="LRG_694t1">
            <Expression>LRG_694t1:c.1860_1861del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_694p1" sequenceAccession="LRG_694p1" change="p.Asp622fs">
            <Expression>LRG_694p1:p.Asp622fs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_025114.3" sequenceAccession="NM_025114" sequenceVersion="3" change="c.1860_1861delAA">
            <Expression>NM_025114.3:c.1860_1861delAA</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000012.11" sequenceAccession="NC_000012" sequenceVersion="11" change="g.88508924_88508925del" Assembly="GRCh37">
            <Expression>NC_000012.11:g.88508924_88508925del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000012.12" sequenceAccession="NC_000012" sequenceVersion="12" change="g.88115147_88115148del" Assembly="GRCh38">
            <Expression>NC_000012.12:g.88115147_88115148del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008417.2" sequenceAccession="NG_008417" sequenceVersion="2" change="g.32070_32071del">
            <Expression>NG_008417.2:g.32070_32071del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_025114.4" sequenceAccession="NM_025114" sequenceVersion="4" change="c.1860_1861del" MANESelect="true">
            <Expression>NM_025114.4:c.1860_1861del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_079390.3" sequenceAccession="NP_079390" sequenceVersion="3" change="p.Asp622fs">
            <Expression>NP_079390.3:p.Asp622fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="386834151" DB="dbSNP" />
        <XRef ID="CA144388" DB="ClinGen" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_025114.4(CEP290):c.1860_1861del (p.Asp622fs) AND Meckel syndrome, type 4" Accession="RCV000050145" Version="1">
        <ClassifiedConditionList TraitSetID="6669">
          <ClassifiedCondition DB="MedGen" ID="C1970161">Meckel syndrome, type 4</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_025114.4(CEP290):c.1860_1861del (p.Asp622fs) AND multiple conditions" Accession="RCV001853067" Version="3">
        <ClassifiedConditionList TraitSetID="22840">
          <ClassifiedCondition DB="MedGen" ID="C0431399">Familial aplasia of the vermis</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0265215">Meckel-Gruber syndrome</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0687120">Nephronophthisis</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-05-24" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-05-24" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2013-07-24" MostRecentSubmission="2024-02-28">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">16909394</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">17345604</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">17564974</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">20690115</ID>
        </Citation>
        <DescriptionHistory Dated="2022-03-25">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="22840" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1878" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Joubert syndrome</ElementValue>
                <XRef ID="MONDO:0018772" DB="MONDO" />
                <XRef Type="Phenotypic series" ID="PS213300" DB="OMIM" />
                <XRef ID="716997004" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cerebelloparenchymal disorder 4</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Joubert-Boltshauser syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">CEREBELLOPARENCHYMAL DISORDER IV</ElementValue>
                <XRef Type="MIM" ID="213300" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Familial aplasia of the vermis</ElementValue>
                <XRef ID="Familial+aplasia+of+the+vermis/8373" DB="Genetic Alliance" />
                <XRef ID="253175003" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">JBTS</ElementValue>
                <XRef Type="MIM" ID="213300" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Classic Joubert syndrome (JS) is characterized by three primary findings: A distinctive cerebellar and brain stem malformation called the molar tooth sign (MTS). Hypotonia. Developmental delays. Often these findings are accompanied by episodic tachypnea or apnea and/or atypical eye movements. In general, the breathing abnormalities improve with age, truncal ataxia develops over time, and acquisition of gross motor milestones is delayed. Cognitive abilities are variable, ranging from severe intellectual disability to normal. Additional findings can include retinal dystrophy, renal disease, ocular colobomas, occipital encephalocele, hepatic fibrosis, polydactyly, oral hamartomas, and endocrine abnormalities. Both intra- and interfamilial variation are seen.</Attribute>
                <XRef ID="NBK1325" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6802" />
                <XRef ID="6802" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301500</ID>
                <ID Source="BookShelf">NBK1325</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGenetest, 2011">
                <ID Source="PubMed">21448235</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2011">
                <URL>http://www.acmg.net/ACMG/UploadedPDFS/PDFDocuments/Carrier-Screening-ACT-SheetAshkenazi-Jewish-Genetic-Disorders.aspx</URL>
                <CitationText>American College of Medical Genetics ACT Sheet, Carrier Screening ACT Sheet Ashkenazi Jewish Genetic Disorders</CitationText>
              </Citation>
              <XRef ID="475" DB="Orphanet" />
              <XRef ID="C0431399" DB="MedGen" />
              <XRef ID="MONDO:0018772" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS213300" DB="OMIM" />
            </Trait>
            <Trait ID="2736" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">DYSENCEPHALIA SPLANCHNOCYSTICA</ElementValue>
                <XRef Type="MIM" ID="249000" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Gruber syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Dysencephalia splachnocystica</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Meckel-Gruber syndrome</ElementValue>
                <XRef ID="29076005" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">MKS</ElementValue>
                <XRef Type="MIM" ID="249000" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">MES</ElementValue>
                <XRef Type="MIM" ID="249000" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="3436" />
                <XRef ID="3436" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="564" DB="Orphanet" />
              <XRef ID="C0265215" DB="MedGen" />
              <XRef ID="MONDO:0018921" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS249000" DB="OMIM" />
            </Trait>
            <Trait ID="16739" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Nephronophthisis</ElementValue>
                <XRef ID="72016" DB="GeneTests" />
                <XRef ID="HP:0000090" DB="Human Phenotype Ontology" />
                <XRef ID="MONDO:0019005" DB="MONDO" />
                <XRef Type="Phenotypic series" ID="PS256100" DB="OMIM" />
                <XRef ID="204958008" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">juvenile nephronophthisis</ElementValue>
                <XRef ID="HP:0000090" DB="Human Phenotype Ontology" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="206" />
                <XRef ID="206" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">The nephronophthisis (NPH) phenotype is characterized by reduced renal concentrating ability, chronic tubulointerstitial nephritis, cystic renal disease, and progression to end-stage renal disease (ESRD) before age 30 years. Three age-based clinical subtypes are recognized: infantile, juvenile, and adolescent/adult. Infantile NPH can present in utero with oligohydramnios sequence (limb contractures, pulmonary hypoplasia, and facial dysmorphisms) or postnatally with renal manifestations that progress to ESRD before age 3 years. Juvenile NPH, the most prevalent subtype, typically presents with polydipsia and polyuria, growth retardation, chronic iron-resistant anemia, or other findings related to chronic kidney disease (CKD). Hypertension is typically absent due to salt wasting. ESRD develops at a median age of 13 years. Ultrasound findings are increased echogenicity, reduced corticomedullary differentiation, and renal cysts (in 50% of affected individuals). Histologic findings include tubulointerstitial fibrosis, thickened and disrupted tubular basement membrane, sporadic corticomedullary cysts, and normal or reduced kidney size. Adolescent/adult NPH is clinically similar to juvenile NPH, but ESRD develops at a median age of 19 years. Within a subtype, inter- and intrafamilial variability in rate of progression to ESRD is considerable. Approximately 80%-90% of individuals with the NPH phenotype have no extrarenal features (i.e., they have isolated NPH); ~10%-20% have extrarenal manifestations that constitute a recognizable syndrome (e.g., Joubert syndrome, Bardet-Biedl syndrome, Jeune syndrome and related skeletal disorders, Meckel-Gruber syndrome, Senior-LÃ¸ken syndrome, Leber congenital amaurosis, COACH syndrome, and oculomotor apraxia, Cogan type).</Attribute>
                <XRef ID="NBK368475" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">27336129</ID>
                <ID Source="BookShelf">NBK368475</ID>
              </Citation>
              <XRef ID="655" DB="Orphanet" />
              <XRef ID="C0687120" DB="MedGen" />
              <XRef ID="MONDO:0019005" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS256100" DB="OMIM" />
              <XRef Type="primary" ID="HP:0000090" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0004748" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
          <TraitSet ID="6669" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="2833" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Meckel syndrome, type 4</ElementValue>
                <XRef ID="MONDO:0012626" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MECKEL-GRUBER SYNDROME, TYPE 4</ElementValue>
                <XRef Type="MIM" ID="611134" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">MKS4</ElementValue>
                <XRef Type="MIM" ID="611134" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15509" />
                <XRef ID="15509" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGenetest, 2011">
                <ID Source="PubMed">21368913</ID>
              </Citation>
              <XRef ID="564" DB="Orphanet" />
              <XRef ID="C1970161" DB="MedGen" />
              <XRef ID="MONDO:0012626" DB="MONDO" />
              <XRef Type="MIM" ID="611134" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="4246846" SubmissionDate="2024-02-15" DateLastUpdated="2024-02-28" DateCreated="2022-03-28">
        <ClinVarSubmissionID localKey="4908216|MedGen:C0431399;C0265215;C0687120" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002231737" DateUpdated="2024-02-28" DateCreated="2022-03-28" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-05-24">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">16909394</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">17345604</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20690115</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">17564974</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Asp622Phefs*5) in the CEP290 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CEP290 are known to be pathogenic (PMID: 16909394, 17345604, 20690115). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with CEP290-related ciliopathy (PMID: 17564974). This variant is also known as c1860_1861delAA (p.Glu620Glufs*7). ClinVar contains an entry for this variant (Variation ID: 56732). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CEP290" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000012.11:g.88508923_88508924del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease" multipleConditionExplanation="Uncertain">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0431399" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0265215" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0687120" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11173117</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14224806</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="131944" SubmissionDate="2013-05-19" DateLastUpdated="2013-07-24" DateCreated="2013-07-24">
        <ClinVarSubmissionID localKey="FINDIS899" />
        <ClinVarAccession Accession="SCV000082555" DateUpdated="2013-07-24" DateCreated="2013-07-24" Type="SCV" Version="1" SubmitterName="Juha Muilu Group; Institute for Molecular Medicine Finland (FIMM)" OrgID="500116" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>probable-pathogenic</GermlineClassification>
          <Comment Type="ConvertedByNCBI">Converted during submission to Likely pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>not provided</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
              <NumberTested>1</NumberTested>
            </Sample>
            <Method>
              <MethodType>not provided</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <CitationList>
            <Citation Type="general">
              <ID Source="PubMed">17564974</ID>
            </Citation>
          </CitationList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_025114.3:c.1860_1861delAA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Meckel syndrome type 4</ElementValue>
            </Name>
            <XRef DB="OMIM" ID="611134" Type="MIM" />
          </Trait>
        </TraitSet>
        <Comment Type="public">FinDis database variant: This variant was not found or characterized by our laboratory, data were collected from public sources: see reference</Comment>
        <SubmissionNameList>
          <SubmissionName>FinDis_mutations</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="131944" TraitType="Disease" MappingType="Name" MappingValue="Meckel syndrome type 4" MappingRef="Preferred">
        <MedGen CUI="C1970161" Name="Meckel syndrome, type 4" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4246846" TraitType="Disease" MappingType="XRef" MappingValue="C0431399" MappingRef="MedGen">
        <MedGen CUI="C0431399" Name="Familial aplasia of the vermis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4246846" TraitType="Disease" MappingType="XRef" MappingValue="C0265215" MappingRef="MedGen">
        <MedGen CUI="C0265215" Name="Meckel-Gruber syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4246846" TraitType="Disease" MappingType="XRef" MappingValue="C0687120" MappingRef="MedGen">
        <MedGen CUI="C0687120" Name="Nephronophthisis" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

